ATE433963T1 - Fab-i inhibitoren - Google Patents
Fab-i inhibitorenInfo
- Publication number
- ATE433963T1 ATE433963T1 AT00928259T AT00928259T ATE433963T1 AT E433963 T1 ATE433963 T1 AT E433963T1 AT 00928259 T AT00928259 T AT 00928259T AT 00928259 T AT00928259 T AT 00928259T AT E433963 T1 ATE433963 T1 AT E433963T1
- Authority
- AT
- Austria
- Prior art keywords
- fab
- inhibitors
- compounds
- useful
- formula
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12992899P | 1999-04-19 | 1999-04-19 | |
US13010199P | 1999-04-20 | 1999-04-20 | |
PCT/US2000/010695 WO2000063187A1 (en) | 1999-04-19 | 2000-04-19 | Fab i inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE433963T1 true ATE433963T1 (de) | 2009-07-15 |
Family
ID=26828036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00928259T ATE433963T1 (de) | 1999-04-19 | 2000-04-19 | Fab-i inhibitoren |
Country Status (8)
Country | Link |
---|---|
US (2) | US6503903B1 (de) |
EP (1) | EP1171428B1 (de) |
JP (1) | JP4647791B2 (de) |
AT (1) | ATE433963T1 (de) |
AU (1) | AU4652000A (de) |
CO (1) | CO5180550A1 (de) |
DE (1) | DE60042401D1 (de) |
WO (1) | WO2000063187A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5180550A1 (es) | 1999-04-19 | 2002-07-30 | Smithkline Beecham Corp | Inhibidores de fab i |
AR024158A1 (es) | 1999-06-01 | 2002-09-04 | Smithkline Beecham Corp | Compuestos antibacterianos |
US6762201B1 (en) | 1999-10-08 | 2004-07-13 | Affinium Pharmaceuticals, Inc. | Fab I inhibitors |
IL148820A0 (en) * | 1999-10-08 | 2002-09-12 | Smithkline Beecham Corp | Fab i inhibitors |
ES2270874T3 (es) * | 1999-10-08 | 2007-04-16 | Affinium Pharmaceuticals, Inc. | Inhibidores de fab i. |
US6730684B1 (en) * | 1999-10-08 | 2004-05-04 | Affinium Pharmaceuticals, Inc. | Fab I inhibitors |
WO2003088897A2 (en) * | 2001-04-06 | 2003-10-30 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
FR2835186B1 (fr) | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
FR2844273B1 (fr) | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens. |
US7439253B2 (en) | 2002-12-06 | 2008-10-21 | Novexel | Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors |
DK1575951T3 (da) * | 2002-12-06 | 2014-09-15 | Debiopharm Int Sa | Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi |
FR2848210B1 (fr) * | 2002-12-06 | 2007-10-19 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases |
EP1608377B1 (de) * | 2003-03-17 | 2008-10-01 | Affinium Pharmaceuticals, Inc. | Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend |
JP5087406B2 (ja) * | 2004-06-04 | 2012-12-05 | アフィニウム ファーマシューティカルズ, インク. | 治療薬ならびにその製造方法および使用方法 |
FR2880625B1 (fr) * | 2005-01-07 | 2007-03-09 | Sanofi Aventis Sa | Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
JP2009518399A (ja) * | 2005-12-05 | 2009-05-07 | アフィニウム ファーマシューティカルズ, インク. | Fabi阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物 |
WO2008009122A1 (en) | 2006-07-20 | 2008-01-24 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as fab i inhibitors |
WO2008098374A1 (en) | 2007-02-16 | 2008-08-21 | Affinium Pharmaceuticals, Inc. | Salts, prodrugs and polymorphs of fab i inhibitors |
US9062075B2 (en) | 2011-12-02 | 2015-06-23 | Aurigene Discovery Technologies Limited | Tetrahydropyridine derivatives as FabI inhibitors |
EP2785715A1 (de) | 2011-12-02 | 2014-10-08 | Aurigene Discovery Technologies Limited | Substituierte pyridinderivate als fabi-inhibitoren |
DK2861608T3 (da) | 2012-06-19 | 2019-06-24 | Debiopharm Int Sa | Prodrug-derivater af (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamid |
EP3004099B1 (de) | 2013-06-04 | 2023-04-19 | Aurigene Oncology Limited | Tetrahydropyridinderivate als fabi-inhibitoren |
CN108778286A (zh) | 2016-02-26 | 2018-11-09 | 德彪药业国际股份公司 | 用于治疗糖尿病足感染的药物 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3828068A (en) | 1971-05-10 | 1974-08-06 | Tenneco Chem | ((substituted indazolyl)-n1-methyl)carbamates |
US4154943A (en) | 1977-12-29 | 1979-05-15 | University Of Vermont | Preparation of vincadifformine |
FR2619111B1 (fr) | 1987-08-07 | 1991-01-11 | Synthelabo | Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique |
AU666318B2 (en) | 1991-06-28 | 1996-02-08 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
AU689762B2 (en) | 1992-12-21 | 1998-04-09 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
US5614551A (en) | 1994-01-24 | 1997-03-25 | The Johns Hopkins University | Inhibitors of fatty acid synthesis as antimicrobial agents |
MX9700041A (es) | 1994-06-29 | 1997-04-30 | Smithkline Beecham Corp | Antagonistas de receptor de vitronectina. |
US6451816B1 (en) | 1997-06-20 | 2002-09-17 | Klinge Pharma Gmbh | Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression |
DE19624659A1 (de) | 1996-06-20 | 1998-01-08 | Klinge Co Chem Pharm Fab | Neue Pyridylalken- und Pyridylalkinsäureamide |
WO1998043969A1 (en) | 1997-03-31 | 1998-10-08 | Dupont Pharmaceuticals Company | Indazoles of cyclic ureas useful as hiv protease inhibitors |
US6207679B1 (en) | 1997-06-19 | 2001-03-27 | Sepracor, Inc. | Antimicrobial agents uses and compositions related thereto |
AU8689798A (en) * | 1997-08-04 | 1999-02-22 | Smithkline Beecham Corporation | Integrin receptor antagonists |
US5932743A (en) | 1997-08-21 | 1999-08-03 | American Home Products Corporation | Methods for the solid phase synthesis of substituted indole compounds |
CO5180550A1 (es) | 1999-04-19 | 2002-07-30 | Smithkline Beecham Corp | Inhibidores de fab i |
AR024077A1 (es) | 1999-05-25 | 2002-09-04 | Smithkline Beecham Corp | Compuestos antibacterianos |
AR024158A1 (es) | 1999-06-01 | 2002-09-04 | Smithkline Beecham Corp | Compuestos antibacterianos |
CO5180605A1 (es) | 1999-06-23 | 2002-07-30 | Smithkline Beecham Corp | Compuestos de indol |
US6346391B1 (en) | 1999-07-22 | 2002-02-12 | Trustees Of Tufts College | Methods of reducing microbial resistance to drugs |
AU1192501A (en) | 1999-10-08 | 2001-04-23 | Smithkline Beecham Corporation | Fab i inhibitors |
ES2270874T3 (es) | 1999-10-08 | 2007-04-16 | Affinium Pharmaceuticals, Inc. | Inhibidores de fab i. |
IL148820A0 (en) | 1999-10-08 | 2002-09-12 | Smithkline Beecham Corp | Fab i inhibitors |
CA2323008C (en) | 1999-10-11 | 2005-07-12 | Pfizer Inc. | Pharmaceutically active compounds |
US6656703B1 (en) | 1999-12-29 | 2003-12-02 | Millennium Pharamaceuticals, Inc. | High throughput screen for inhibitors of fatty acid biosynthesis in bacteria |
US6372752B1 (en) | 2000-02-07 | 2002-04-16 | Genzyme Corporation | Inha inhibitors and methods of use thereof |
HUP0400651A2 (hu) | 2000-11-07 | 2004-06-28 | Bristol-Myers Squibb Company | Szerin proteáz inhibitorokként alkalmazható savszármazékok és ezeket tartalmazó gyógyszerkészítmények |
WO2002048097A1 (en) | 2000-12-12 | 2002-06-20 | Corvas International, Inc. | Compounds, compositions and methods for treatment of parasitic infections |
-
2000
- 2000-04-14 CO CO00027745A patent/CO5180550A1/es unknown
- 2000-04-19 AT AT00928259T patent/ATE433963T1/de not_active IP Right Cessation
- 2000-04-19 EP EP00928259A patent/EP1171428B1/de not_active Expired - Lifetime
- 2000-04-19 DE DE60042401T patent/DE60042401D1/de not_active Expired - Lifetime
- 2000-04-19 AU AU46520/00A patent/AU4652000A/en not_active Abandoned
- 2000-04-19 WO PCT/US2000/010695 patent/WO2000063187A1/en active Application Filing
- 2000-04-19 JP JP2000612279A patent/JP4647791B2/ja not_active Expired - Fee Related
-
2001
- 2001-10-18 US US09/959,172 patent/US6503903B1/en not_active Expired - Lifetime
-
2002
- 2002-11-12 US US10/292,687 patent/US6765005B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6503903B1 (en) | 2003-01-07 |
CO5180550A1 (es) | 2002-07-30 |
EP1171428B1 (de) | 2009-06-17 |
EP1171428A1 (de) | 2002-01-16 |
US20030139377A1 (en) | 2003-07-24 |
US6765005B2 (en) | 2004-07-20 |
EP1171428A4 (de) | 2004-09-15 |
WO2000063187A1 (en) | 2000-10-26 |
AU4652000A (en) | 2000-11-02 |
DE60042401D1 (de) | 2009-07-30 |
JP4647791B2 (ja) | 2011-03-09 |
JP2002542235A (ja) | 2002-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60042401D1 (de) | Fab-i inhibitoren | |
ECSP003699A (es) | Inhibidores de fab i | |
MY138285A (en) | Fab i inhibitors | |
TR200200160T2 (tr) | Antiinflamatuar ajanlar olarak imidazoller ve triazoller | |
NO20052362D0 (no) | Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner | |
DE60327438D1 (de) | Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen | |
ATE340171T1 (de) | Piperazinderivate zur behandlung bakterieller infektionen | |
NO20005400L (no) | Kinoloner anvendt som MRS-inhibitorer og baktericider | |
DE69928952D1 (de) | Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe | |
CY1106958T1 (el) | Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα | |
TR200002480T2 (tr) | İzaşemi tedavisi için guanidin türevleri | |
AP2003002824A0 (en) | Gyrase inhibitors and uses thereof | |
NO20003233D0 (no) | 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler | |
NO20014314L (no) | Blandinger og metoder for behandling av stafylokokkisk infeksjon | |
NO20025204D0 (no) | Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner | |
NO331012B1 (no) | N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
NZ510369A (en) | Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection | |
DE60121345D1 (de) | Alkylierte imidazopyridinderivate | |
DE60115466D1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
NO20044549L (no) | Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer | |
SE0003476D0 (sv) | Compounds | |
NO20043445L (no) | Kombinasjonsterapi for behandling av bakterielle infeksjoner | |
NZ509051A (en) | Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use | |
NO20005548D0 (no) | Mykobakterieinhibitorer | |
BR0313400A (pt) | N-aril-2-oxazolidinonas e seus derivados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |